Compare VOR & DJCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VOR | DJCO |
|---|---|---|
| Founded | 2015 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 767.4M | 706.2M |
| IPO Year | 2021 | 1995 |
| Metric | VOR | DJCO |
|---|---|---|
| Price | $13.73 | $529.80 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $45.33 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 68.1K |
| Earning Date | 05-13-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.50 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $41,384,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.13 | $348.63 |
| 52 Week High | $49.95 | $674.75 |
| Indicator | VOR | DJCO |
|---|---|---|
| Relative Strength Index (RSI) | 42.32 | 53.41 |
| Support Level | $11.38 | $485.65 |
| Resistance Level | $16.87 | $557.95 |
| Average True Range (ATR) | 1.23 | 26.72 |
| MACD | -0.25 | 1.03 |
| Stochastic Oscillator | 3.32 | 54.69 |
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies which includes Journal Technologies, Inc. and Journal Technologies (Canada) Inc. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Traditional segment.